Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Canagliflozin in T1DM After Interruption of Continuous Subcutaneous Insulin Infusion

NCT02673138 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT02673138
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02673138 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Canagliflozin in T1DM After Interruption of Continuous Subcutaneous Insulin Infusion
Lead sponsor
Yale University
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2016
Completion date
July 31, 2017
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes